SAP 35, surfactant-associated protein of Mr = 35,000 daltons CLSE, calf lung surfactant extract LS, lung surfactant SAP, surfactant-associated protein Mammalian pulmonary surfactant is a complex material containing primarily phospholipids and associated proteins or apolipoproteins. Evidence from a number of laboratories supports the concept that in addition to lung surfactant phospholipids, some of these protein components are required for the full biological activity of surfactant in reducing surface tension in the alveoli (1) (2) (3) (4) (5) (6) (7) (8) . Several exogenous surfactant preparations that are based on organic solvent extraction of mammalian lung lavage and contain only small amounts of lung protein (1-2%) have been successfully utilized in the treatment of hyaline membrane disease. Such lung surfactant extracts were used in initial clinical studies by Smyth et al. (9) and Fujiwara et al. (10) . Efiicacy for a specific CLSE has now been demonstrated in three recent controlled, double-blind clinical trials by Kwong et al. (1 l) , Shapiro et al. (12) , and Enhorning et al. (13) for the prevention of hyaline membrane disease in infants. One of the aims of the present work is to define in more detail the protein composition of the biophysically and physiologically active surfactant replacement extract preparations CLSE (9, (11) (12) (13) and surfactant-TA (14) .
The major surfactant-associated protein of Mr = 30-40,000
daltons, first identified in lung surfactant by King el al. (16) , are glycoproteins rich in glycine and containing collagen-like regions rich in hydroxyproline (17, 18) . This protein, herein called SAP-35, is synthesized from Mr = 28-30,000 dalton translation products which undergo glycosylation, hydroxylation of proline residues, and sulfhydryl-dependent cross-linking to form larger oligomers which are detected in the airway (i9-25). SAP-35 and smaller surfactant-associated proteins have also been identified from a variety of mammalian surfactants (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) . The nature and relationships among the various SAPS and the larger protein, SAP-35 or its fragments, have not been entirely established. It has been suggested that smaller molecular weight proteins arise as proteolytic fragments of the larger molecule (32) . It is, however, possible that one (or more) of the smaller molecular weight proteins in lung surfactant is a distinct entity with independent function and importance. It is thus unclear at present whether SAP-35, one or more of the smaller proteins, or all proteins together are active components imparting biophysical activity to mammalian surfactant. In the present work we have purified and partially characterized hydrophobic protein of Mr = 6,000 and 14,000 daltons from the surfactant of several mammalian species, herein called SAP 6-14. The characteristics of this protein are compared and contrasted with those of SAP-35 and its fragments. These results are also correlated with data on the hydrophobic protein found in the surfactant replacement extract preparations CLSE and surfactant-TA to support a role of SAP 6-14 in surfactant function.
MATERIALS AND METHODS
SAPfrom mammalian lung lavage surfactant. SAP were isolated from lung lavage material obtained from adult dogs and cows after sacrifice. In addition, proteins were isolated from human surfactant obtained from human cadavers following autopsy, from human amniotic fluid at term and from selected bronchial washes from the lungs of patients with alveolar proteinosis. Protocols involving human material were approved by the Committee on Human Research, University of Cincinnati College of Medicine. In animal studies, the trachea was cannulated and the lung lavaged three times with several lung volumes of iced 0.9% NaCl, 50 mM Na2HP04, and 5 mM EDTA, pH 7.2. Cells and debris were removed by centrifugation at 800 x g for 10 min (twice) and a particulate fraction was then collected by centrifugation at 40,000 x g for 30 min at 4" C. The pelleted material was diluted in the above buffer containing 1 mM phenylmethylsulfonylfluoride and sonicated for 10 s with a Branson sonifier. Surfactant was then pelleted by centrifugation at 40,000 x g for 30 min at 4" C.
The surfactant pellet was further processed by extraction in etherlethano1 (3: I) at -30" C for 16 h (16). Particulate material was removed from the extraction by centrifugation and utilized for the purification of SAP-35 as previously described (17, 23) . Etherlethano1 fractions containing SAP 6-14 were evaporated to near dryness and redissolved in chloroform. Purification of SAP 6-14 then proceeded essentially as described by Phizackerley et al. (30) . The dried residue was dissolved in chloroform and applied to a BioSil HA column (2.5 x 40 cm, Bio-Rad, Richmond, CA) equilibrated in chloroform. Lipid-protein fractions were recovered by stepwise elution with chloroform-methanol mixtures (200 ml each) with stepwise increase in concentration of methanol (10% intervals) in chloroform. Aliquots from each column fraction were assayed for protein by SDS-PAGE (see below). The purified protein was also quantitated by a fluorescamine assay using bovine serum albumin as standard in the presence of 1% SDS (34) . However, lipid eluting earlier than SAP 6-14 on the silicic acid column also reacted with fluorescamine and thus this assay could not be used to quantitate the amount of protein applied or recovered.
SAP from surfactant replacement preparations. CLSE was prepared by chloroform-methanol extraction (35) from saline lavage of calf lungs as described in detail previously by Notter and coworkers (2, 3, 1 1, 12, 36, 37). Whole calf LS was also obtained from the same lavage sample by centrifugation after cell removal (2), and was used for comparative analysis of biophysical properties as described later. The phospholipid composition of whole LS and CLSE was defined by thin layer chromatographic analysis with the solvent system of Touchstone et al. (38) . The phospholipid class distribution was 8 1 % phosphatidylcholine, 6.7% phosphatidylglycerol, 6% phosphatidylinositol (+phosphatidylserine), 4.3% phosphatidylethanolamine, and 2% sphingomyelin. The CLSE contained 94% phospholipid by weight while natural LS from the same lavage was 86% phospholipid [based on an overall phospholipid molecular weight average of 750 daltons, and using the microphosphorous assay of Ames (39) l. The total protein content of the CLSE preparation was <1.5%, compared to 1 I% for natural LS, using a modification of the method of Lowry et al. (40) in which the assay was performed in 1 .O% SDS to analyze for protein in the presence of lipid. The remainder of both LS and CLSE was predominantly the neutral lipid cholesterol.
The surfactant replacement extract preparation, surfactant-TA, was also analyzed for SAP. This preparation was provided through the cooperation of Abbott Laboratories, N. Chicago, IL. Surfactant-TA is a chloroform-methanol extract of minced lungs from cows, supplemented with dipalmitoyl phosphatidylcholine and other phospholipids and neutral lipids including free fatty acids (14) . Fujiwara (14) has presented the representative chemical composition of surfactant-TA lipid, which comprises about 98% of the mixture. The remainder of the preparation, approximately 2%, is protein.
Further detailed analysis of the surfactant-associated protein remaining in CSLE and surfactant-TA after chloroform-methano1 extraction was carried out essentially as described above. CLSE or surfactant-TA was placed in chloroform:methanol(2: 1) prior to gel analysis. A small amount of flocculent material precipitated from the chloroform:methanol solution was removed by centrifugation at 10,000 x g for 20 min before rotoevaporation, addition of chloroform and application to silicic acid columns. In some cases, protein was further delipidated prior to analysis using Sep-packs from Waters, Inc., Milford, MA. CLSE and surfactant-TA protein was applied to the Seppack in chloroform and eluted from the column with increasing concentrations of methanol.
Gel analysis of SAP. Proteins were analyzed after separation using SDS-polyacrylamide gels (Integrated Separations Systems Inc., from Fisher Scientific, Cincinnati, OH) made either 3-27 or 10-20% polyacrylamide. Samples were lyophilized and resuspended in sample buffer as described by Laemmli (41) , in the presence of P-mercaptoethanol. Gels were stained using slight modification of the procedures of Sammons et al. (42) in which 5% acetic acid was used to control background staining following a 5-10 min Na2C03 color development step. Molecular weight markers included trypsin inhibitor (6,300), lysozyme (14,000), P-lactalbumin (18,400), a-chymotrypsin (25,700), and ovalbumin (43,000) purchased from BRL Incorporated, Bethesda, MD.
Zmmunoblot analysis of bovine SAP. Monospecific antisera was prepared against bovine SAP-35 by repeated injection of approximately 500 ~g of the protein in Freund's complete adjuvant into rabbits. Antigen was homogeneous as assessed by silver staining of one-and two-dimensional SDS-PAGE analysis. The resultant antisera were not reactive against bovine serum albumin or bovine serum. For immunoblot analysis, whole bovine surfactant was separated by SDS gel electrophoresis and subjected to immunoblot as previously described (23) . Proteins were transferred electrophoretically to nitrocellulose, treated with anti-SAP-35 antibody followed by horseradish peroxidase-conjugated goat anti-rabbit IgG, and developed as described by Towbin et al. (43) except that 0.05% 4-chloro-napthol was used as the substrate.
Analysis of protein utilizing protease and endoglycosidase treatment. Purified canine SAP-35 and purified canine SAP 6-14 were resuspended in I % SDS. Aliquots were then diluted in indicated buffers with the following concentrations of digestive enzymes: endoglycosidase F (50 mM sodium phosphate, pH 6.1 0.1% NP-40, 10 mM disodium EDTA, and 0.1 to 4 U of endoglycosidase F per ml); collagenase (50 mM Tris-HC1, pH 7.3, 150 mM NaCl, 0.1 % NP-40, 0.5 mM MgSO,, 0.5 mM CaCI,, and 3-100 U of bacterial collagenase per ml); and neuraminidase (50 mM sodium acetate, pH 5.5, 150 mM NaCl, 4 mM CaC12 and 0.1-0.3 U of neuraminidase per ml). Digestions were carried out at 37" C for 16 to 20 h. In the case of SAP 6-14, proteolytic digestion was repeated by the subsequent additions of identical amounts of degrading enzymes. Tryptic maps were prepared after iodinating the proteins by the chloramine T method, as previously described (23) . Iodinated proteins were cut from the gel and resuspended in 50 mM sodium acetate, pH 8, and incubated with chymotrypsin (50 Fg/ml) and trypsin (50 pg/ml) for 16 h at 24" C. Iodopeptides were then isolated by electrophoresis and thin-layer chromatography as described by Gibson (44) and subjected to autoradiography in parallel with peptides from SAP-35. In separate experiments trypsin digests of the canine SAP-35 were performed in the presence and absence of both I % NP-40 or 1 % SDS.
Amino acid composition of SAP. SAP-35 and hydrophobic protein SAP 6-14 from canine and bovine surfactants were purified, reduced, and alkylated and hydrolyzed in 30 of 5.0 M HCI, containing 0.3% phenol, 0.1 % P-mercaptoethanol at 110" under vacuum (17) . Free amino acids were determined using a Beckman 6300 amino acid analyzer.
Biophysical analyses of CLSE surfactant activity. Biophysical characterizations of surfactant activity were carried out by two techniques: 1) adsorption measurements in the absence of a diffusion resistance and 2) dynamic surface tension lowering utilizing an oscillating bubble apparatus. Details of adsorption experiment methodology have been given previously by Notter and coworkers (2, 3, 36, 37) . In brief, aliquots of a surfactant dispersion were added at time zero to a stirred surfactant-free subphase, and subsequent surface tension lowering followed as a function of time using a sandblasted platinum Wilhelmy slide connected to a force transducer. Adsorption measurements were made at 35 a 2" C. In addition to isolated adsorption facility, an oscillating bubble apparatus, equivalent in design to that of Enhorning (45) , was used to measure a combination of dynamic surface tension lowering, respreading, and adsorption properties as described in detail by Notter and coworkers (3, 36, 37) . Bubble measurements were made at 37" C and 100% humidity, with a cycling rate of 20 cycles/min and an area compression of 50%.
RESULTS

Characteristics of SAP-35 and SAP 6-14.
Extraction of whole lung surfactant from all species studied (human, dog, cows, rats) with etherlethano1 results in separation of the two major protein components of surfactant. Using the etherlethano1 extraction technique, the insoluble material contains virtually all of the SAP-35, Mr = 32,000-36,000 daltons (after sulfhydryl reduction) which was readily detected by Coomassie (Fig. 1 ) and silver staining analysis or by immunoblot with monospecific anti-
. , . . . . canine or anti-bovine SAP-35 antisera generated against either bovine or canine SAP-35, respectively. This precipitate does not contain SAP 6-14. Conversely, etherlethano1 soluble fractions did not contain detectable SAP-35 by either method and were utilized for purification of SAP 6-14. Purified SAP 6-14 from the canine preparation is seen on Figure 1 .
The abundance of lipid in the starting material for SAP analyses made precise demonstration of any small molecular weight protein components impossible. Silver stained material and lipid migrate with the solvent front ( Fig. 2A) . However, purification and delipidation of the etherlethano1 extractable protein and subsequent analysis by SDS-PAGE resulted in detection of silverstained material (Fig. 2) or Coomassie stained material (Fig. 1) which migrated with Mr = 6,000 and 14,000 daltons. Protein purification for these analyses began by elution from silicic acid columns at approximate concentrations of 2:3 chloroform:methanol as the eluant solvent (Fig. 2C) . Silver stained material at Mr = 6,000 and 14,000 correlated with a protein peak eluted from the column as assessed by the fluorescamine assay (not shown), although a major lipid fraction was also reactive with fluorescamine but lacked SAP 6-14 by gel analysis. Delipidated, etherlethano1 soluble proteins were purified from bovine, canine, and human natural lung surfactant as represented by Figure 3 . In all species, protein migrating with molecular weight 6,000 and 14.000 daltons was the only protein detected in the etherlethanoi soluble fraction. As shown in Figures 2 and  3 , this protein of Mr = 6,000 and 14,000 daltons could be resolved into two distinct bands utilizing SDS-PAGE gradient gels and various staining methods. When larger amounts of protein were loaded, bands were also detected at Mr = 20,000 and Mr = 26,000, the large forms likely representing oligomers of SAP-6,000.
To determine whether the 6-14,000 dalton protein was structurally similar to the major SAP, SAP-35, both proteins were subjected to digestion with a number of proteases and with endoglycosidase F. As in previous studies (19, 2 1, 23) , canine SAP-35 was degraded by endoglycosidase F, which cleaves asparagine-linked oligosaccharides, with a resultant Mr = 28-30,000 dalton form of canine protein. Since the 35,000 dalton SAP-35 is also known to be sensitive to bacterial collagenase and trypsin (17, 21, 23) , similar digestions with thermolysin and papain was carried out with SAP 6-14. In all cases, SAP 6-14 hydrophobic proteins were entirely resistant to protease treatment in marked contrast to the susceptibility of SAP-35. Boiling the sample, the addition of 1% NP-40, 1% SDS or 6 M urea prior to digestion, as well as repeated digestions, all failed to cleave SAP 6-14 under conditions in which SAP-35 was degraded to fragments which migrated in the front of the SDS-PAGE gels. Similarly, tryptic-chymotryptic digests of the iodinated SAP 6-14 were compared with such digests of canine SAP-35. Chymotryptic-tryptic digests of SAP-35 resulted in at least six highly reproducible spots as previously reported (I 7, 19,23) . In contrast, while some labeled peptides of Mr = 6,000 and 14,000 were detected, most of the labeled material remained near the origin of the plates and no distinct peptides were identified which comigrated with the peptides identified from SAP-35 (not shown).
The marked differences between SAP 6-14 and SAP-35 in terms of solubility in organic solvents, and in their sensitivity to degradation by proteases and endoglycosidase F, also supported the concept that these proteins are not closely related. In addition, amino acid composition of SAP 6-14 was determined from canine and bovine preparations, and the results given in Table  1 . The amino acid composition of canine SAP-35 previously reported by our laboratory (Table I) , is clearly distinct from the amino acid composition of SAP 6-14. The relative proportion of leucine and cysteine in hydrophobic SAP 6-14, for example, is much higher than in SAP-35. The amino acid composition results in Table 1 indicate that it is highly unlikely that SAP 6- Fig. 2 . Purification of canine SAP 6-14 from etherlethano1 extracts of surfactant assessed by silver staining. A represents starting material. Lipid and protein migrated near the buffer front. Purified canine SAP 6-14 (B) migrates as two distinct bands of 6,000 and 14,000 daltons. Faint amounts are observed at Mr = 20,000 and 26,000 although not visualized here. C represents the profile of protein elution from the Biosil-HA column by increasing proportions of methanol in chloroform as described in "Materials and methods." Staining at 65-69,000 daltons is the 0-mercaptoethanol artifact. Fraction 6 contained protein assessed either by fluorescamine assay or by silver staining after elution by 3:2 chloroform:methanol. This eluted material was then utilized for Sep-pack chromatography for further delipidation as described in "Materials and methods." Delipidated protein, approximately 2 pg, is shown in B. The electrophoresis buffer front is marked (A.
14 originated from linear amino acid sequences derived from SAP-35.
To further assess possible relationships among these proteins, monospecific antisera were prepared against bovine SAP-35 and were utilized for immunoblot analysis of whole bovine surfactant and purified bovine SAP 6-14. Anti-SAP-35 readily detected a broad band of protein Mr = 35,000 but did not react with protein Mr = 6,000 and 14,000 (Fig. 4) .
Protein in surfactant extract replacement preparations. Relationships among SAP 6-14 and protein from the surfactant extract replacement preparations CLSE and surfactant-TA were assessed. Ethanol-ether extracts of these preparations did not result in detectable precipitation of SAP-35. CLSE and surfactant-TA were then purified as described for the surfactant-associated etherlethano1 soluble proteins described above. The results shown in Figure 5 demonstrate that the identical 6,000 and 14,000 dalton protein detected in etherlethano1 extracts of lung surfactant was present in both CLSE and surfactant TA; proteins of larger molecular weight were not detected in significant quantities. In particular, protein corresponding to SAP-35 was not detected by immunoblot analysis with anti-SAP-35 antibodies.
Comparative biophysical activity of whole surfactant and CLSE extract. In order to permit inferences about the importance and relative effectiveness of SAP 6-14 in terms of biophysical activity, it was necessary to compare the surface activity of the CLSE replacement extract with that of the whole calf LS from which it is derived. This was done by means of both adsorption and oscillating bubble measurements (see "Materials and methods") which documented that the biophysical activity of CLSE and whole LS was equivalent, even though the former contained only the SAP 6-14, without significant SAP-35.
The isolated adsorption facility of LS and CLSE is shown in the surface pressure-time (a-t) isotherms of Figure 6 for a bulk phase concentration of 0.063 mg of surfactant phospholipid per ml. The CLSE is the same preparation studied for protein content in Figure 5 . Isotherms are represented for a number of different conditions known to affect LS or CLSE adsorption facility. Curve I on Figure 6 shows that CLSE dispersed in saline by sonication for 1 min at 25 W power (2, 37) adsorbs with extreme rapidity to surface pressures greater than 45 dyneslcm. Natural LS with Ca" ions added in curve 3, and CLSE dispersions formed by mechanical vortexing (2, 36, 37) in curve 2, adsorb slightly less rapidly at this low subphase concentration of 0.06 mg phospholipidlml. At higher concentrations of 0.125 mg/ml, however, both CLSE dispersed by vortexing and natural LS with calcium ions exhibited the same maximal adsorption facility' as sonicated CLSE dispersions (not shown explicitly). These data demonstrate that in terms of adsorption behavior, the CLSE replacement extract has activity as high as that of whole surfactant.
Because dynamic surface tension lowering properties are ' The term "maximal adsorption" is used to denote adsorption in seconds to surface pressures approaching the equilibrium spreading pressure limit of phospholipids, which does not exceed 45-50 dynes/cm (3). It is important to note that mixtures of synthetic phospholipids alone, which are of similar composition to CLSE but without any protein, are not able to achieve maximal adsorption equivalent to LS and CLSE preparations in Figure 6 , as shown previously by Notter et al. (2) . This is presumptive evidence that the protein in LS and CLSE, even though present in small amounts particularly in the latter, is important for optimal surface activity.
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WHITSETT ET AL. Fig. 3 . SAP 6-14 from human, canine, and bovine surfactants. Proteins were purified and delipidated as described in "Materials and methods," and applied to 10-20% sodium dodecylsulfate-polyacrylamide gel electrophoresis gels in presence of P-mercaptoethanol. Each lane represents approximately 2 pg proteins detected by silver staining. The purified protein from each species, a = human, b = bovine, c = canine, migrated with Mr = 6,000 and 14,000. The P-mercaptoethanol artifact is also observed at Mr = 65-70,000. Standard molecular weight markers are seen on the right. thought to be critical for LS function in respiration (3, 46) , the surface activity of LS and CLSE was also defined here by oscillating bubble measurements. Results of these determinations are shown in Table 2 . The data show that both LS and CLSE can generate minimum surface tensions less than 1 dyne/cm for concentrations ranging from 0.5 to 5 mg/ml. In addition, at a given concentration, the times necessary for this minimum to be reached after the start of bubble pulsation were essentially equivalent for LS compared to CLSE across this concentration range studied. These results demonstrate the comparable dynamic surface activity of whole surfactant and the CLSE preparations studied here for protein composition.
DISCUSSION
In the present work we have isolated hydrophobic proteins of molecular weight 6,000 and 14,000 daltons from pulmonary surfactant from human, canine, and bovine lung lavage. These proteins were readily distinguished from surfactant associated SAP-35 by peptide mapping, resistance to proteases, and endoglycosidase F, as well as by amino acid composition. SAP 6-14 --* Purified protein samples were hydrolyzed in 300 p1 5.7 N HCl, 0.3% phenol, 0.01% 0-mercaptoethanol at 110°C under vacuum. Free amino acids were resolved using a Beckman 6300 acid analyzer.
t Estimated average molecular weight = 10,000 daltons.
$ Estimated molecular weight = 26,000 daltons for peptide portion.
is a distinct protein and does not represent material previously termed "apoprotein B" since, in contrast to SAP 6-14, the smaller molecular weight protein designated apoprotein B was isolated from ether:ethanol precipitates of canine surfactant (16) . Hydrophobic small molecular weight proteins were found to be the only significant proteins detected by silver stain analysis of the exogenous surfactant replacement extracts CLSE (formerly called calf lung lipid) and surfactant-TA. The CLSE preparation studied here displayed all the beneficial biophysical properties of natural surfactant in terms of dynamic surface tension lowering and adsorption, in agreement with earlier biophysical studies (2, 3, 47) . In addition, the physiologic activity of CLSE has been verified in previous studies involving restoration of lung function and mechanics in several surfactant-deficient animal models (36, 37, 48, 49) and in three recently reported trials of surfactant replacement therapy for human infants with respiratory distress syndrome ( 1 1-1 3) . Surfactant properties and physiologic efficacy of surfactant-TA have also been demonstrated in both animal and clinical studies (10, 14, 50) . SAP 6-14 isolated here from mammalian surfactants and from replacement surfactant preparations was found to be remarkably hydrophobic in nature. The amino acid compositions determined for the cow and dog proteins, although not identical, were quite similar. The SAP 6-14 proteins from these species were also similar in terms of electrophoretic migration in SDS-PAGE gels. SAP 6-14 from all animals tested was highly resistant to protease digestion. These results suggest that SAP 6-14 are related peptides with similar structure and functions in the species tested (dog, human, bovine). We suggest that higher molecular weight forms (Mr = 14,000, 20,000, and 26,000) represent multimers of the SAP 6 protein. Recent immunologic studies and Nterminal amino acid determination of the SAP 6-14 preparations support this premise (51; Whitsett JA, Hull WM, Ohning B, Ross G, Weaver T, Meuth J, unpublished observations).
Previous studies regarding the timing of the appearance of small molecular weight proteins in lung lavage after radiolabeling t Concentration is expressed in mg of surfactant phospholipid per ml of 0.15 M NaCl subphase in which an air bubble is formed at time zero, and pulsation started at 20 cycles/min. LS was resuspended from a centrifuged pellet for bubble studies, while CLSE was dispersed by mechanical vortexing after evaporation from chloroform under nitrogen (3, 36, 37 (30) and is distinct from "apoprotein B" (16) . In the studies of Phizackerley et al. (30) several peptides of approximately 9-16,000 daltons were identified utilizing purification and delipidation procedures similar to those used here.
Phizackerley et al. (30) identified an identical NH2-terminal amino acid from several of these proteins. These findings and the remarkable resistance of all SAP 6-14 peptides studied to protease and endoglycosidase digestion, as well as their equivalent partition into the organic rather than aqueous solvents, strongly support a similar functional role and structural relatedness (possibly as oligomers) for these low molecular weight hydrophobic proteins observed in the different species studied.
Aside from comparing and contrasting the composition and properties of SAP-35 and SAP 6-14, a major emphasis of our experiments was to characterize the protein component of lung surfactant extract mixtures. In particular, because of the importance of the clinical use of surfactant replacement extracts, and the lack of clarity regarding the nature and origins of the proteins in those preparations, we compared the hydrophobic proteins purified from lung lavage with the proteins isolated from the clinically tested surfactant extract replacement preparations CLSE and surfactant-TA (10) (11) (12) (13) (14) . These preparations contained the hydrophobic SAP 6-14 protein, which comigrated with those isolated from mammalian whole surfactant. Surfactant associated SAP-35, and the more abundant serum proteins present in whole surfactant, were not present in significant quantities in CLSE or surfactant-TA. Results for surfactant-TA, confirm and extend the previous work of Tanaka et al. (3 1) and Suzuki et al. (29) who demonstrated small molecular weight proteins in surfactant extracts of minced lungs from cows and porcine surfactant, the former being the base material for surfactant-TA (14) .
The amino acid composition reported by Tanaka et al. (3 1 ) for surfactant extracts from minced cow lungs was similar to that obtained for the bovine SAP 6-14 presently reported.
In terms of surfactant function, our results show that SAP 6-14 protein, in the presence of natural surfactant lipids, is associated with full biophysical activity of the CLSE surfactant extract used for replacement therapy for respiratory distress syndrome (1 1-13 ). This biophysical activity of rapid adsorption and good dynamic surface tension lowering has been demonstrated to result in beneficial effects of CLSE on lung function and mechanics in surfactant-deficient animal lung models (3, 36, 37, 48, 49) and in clinical therapy with respiratory distress syndrome infants (9-13). Similar findings hold for the related lung surfactant extract preparation, surfactant-TA (14) . The precise role of SAP 6-14 in this activity remains to be clarified. SAP 6-14 is markedly resistant to protease digestion supporting its stability and suitability for replacement surfactants. While natural surfactant from lung lavage contains a large number of detectable proteins, including both serum and nonserum protein, the major protein, SAP-35, and the other less abundant proteins do not appear to be required for the biophysical activity of the CLSE and surfactant-TA surfactant preparations.
It should be noted that our results do not exclude the possibility that SAP-35 plays a role in lung surfactant physical physical function in vivo. Surfactant extracts such as CLSE are not equivalent to natural LS; they are dispersed by mechanical means, e.g. sonication, mechanical agitation, in an aqueous phase prior to use. This allows extracts such as CLSE or surfactant-TA to achieve active aqueous dispersion microstructures not available to natural LS in vivo. Notter et al. (52) have recently shown that CLSE can adsorb as rapidly as natural LS without forming the distinctive microstructure of tubular myelin, associated with optimal adsorption of the latter (52) (53) (54) . Thus, SAP-35 could be involved in natural LS activity in vivo, but in ways that are by-passed in mechanically dispersed extracts so that the extracts can be surface active without the necessity for SAP-35. In a practical sense, however, the results here show that good biophysical activity in exogenous surfactants can be achieved with extracts containing only SAP 6-14. Moreover, it is this protein which is so specifically associated with surfactant phospholipids that it retains this relationship to the extent of remaining with them during organic solvent extraction. The further understanding of SAP 6-14 and clarification of its potential biophysical properties may lead to new strategies for the treatment of hyaline membrane disease and other surfactant deficient states. For example, if semisynthetic surfactants are formulated in vitro using synthetic phospholipids combined with small amounts of surfactant proteins, this might specifically involve SAP 6-14.
